ZYNEX INC (ZYXI) Fundamental Analysis & Valuation

NASDAQ:ZYXI • US98986M1036

Current stock price

0.125 USD
-0.07 (-34.9%)
At close:
0.13 USD
+0.01 (+4%)
After Hours:

This ZYXI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ZYXI Profitability Analysis

1.1 Basic Checks

  • In the past year ZYXI has reported negative net income.
  • ZYXI had a negative operating cash flow in the past year.
  • Each year in the past 5 years ZYXI has been profitable.
  • ZYXI had a positive operating cash flow in each of the past 5 years.
ZYXI Yearly Net Income VS EBIT VS OCF VS FCFZYXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

  • ZYXI has a Return On Assets of -163.18%. This is amonst the worse of the industry: ZYXI underperforms 88.17% of its industry peers.
Industry RankSector Rank
ROA -163.18%
ROE N/A
ROIC N/A
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
ZYXI Yearly ROA, ROE, ROICZYXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • In the last couple of years the Profit Margin of ZYXI has declined.
  • ZYXI's Operating Margin has declined in the last couple of years.
  • ZYXI's Gross Margin of 71.90% is amongst the best of the industry. ZYXI outperforms 81.18% of its industry peers.
  • ZYXI's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ZYXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.9%
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
ZYXI Yearly Profit, Operating, Gross MarginsZYXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ZYXI Health Analysis

2.1 Basic Checks

  • ZYXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZYXI has been reduced compared to 1 year ago.
  • ZYXI has less shares outstanding than it did 5 years ago.
  • ZYXI has a worse debt/assets ratio than last year.
ZYXI Yearly Shares OutstandingZYXI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ZYXI Yearly Total Debt VS Total AssetsZYXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -2.75, we must say that ZYXI is in the distress zone and has some risk of bankruptcy.
  • ZYXI's Altman-Z score of -2.75 is on the low side compared to the rest of the industry. ZYXI is outperformed by 63.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.75
ROIC/WACCN/A
WACC4.78%
ZYXI Yearly LT Debt VS Equity VS FCFZYXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.47 indicates that ZYXI may have some problems paying its short term obligations.
  • ZYXI has a worse Current ratio (0.47) than 91.94% of its industry peers.
  • A Quick Ratio of 0.32 indicates that ZYXI may have some problems paying its short term obligations.
  • ZYXI's Quick ratio of 0.32 is on the low side compared to the rest of the industry. ZYXI is outperformed by 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.32
ZYXI Yearly Current Assets VS Current LiabilitesZYXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ZYXI Growth Analysis

3.1 Past

  • The earnings per share for ZYXI have decreased strongly by -540.63% in the last year.
  • Measured over the past years, ZYXI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.77% on average per year.
  • ZYXI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.13%.
  • Measured over the past years, ZYXI shows a very strong growth in Revenue. The Revenue has been growing by 33.42% on average per year.
EPS 1Y (TTM)-540.63%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-671.43%
Revenue 1Y (TTM)-44.13%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-73.26%

3.2 Future

  • The Earnings Per Share is expected to decrease by -28.28% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -7.81% on average over the next years.
EPS Next Y-1584.67%
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue Next Year-52.33%
Revenue Next 2Y-27.82%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZYXI Yearly Revenue VS EstimatesZYXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ZYXI Yearly EPS VS EstimatesZYXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. ZYXI Valuation Analysis

4.1 Price/Earnings Ratio

  • ZYXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZYXI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZYXI Price Earnings VS Forward Price EarningsZYXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZYXI Per share dataZYXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as ZYXI's earnings are expected to decrease with -60.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZYXI Dividend Analysis

5.1 Amount

  • ZYXI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZYXI Fundamentals: All Metrics, Ratios and Statistics

ZYNEX INC

NASDAQ:ZYXI (12/23/2025, 8:00:03 PM)

After market: 0.13 +0.01 (+4%)

0.125

-0.07 (-34.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-17
Earnings (Next)03-09
Inst Owners13.71%
Inst Owner Change-82.46%
Ins Owners47.94%
Ins Owner Change0%
Market Cap3.80M
Revenue(TTM)108.20M
Net Income(TTM)-73.96M
Analysts82.5
Price Target2.91 (2228%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)-65.69%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-176.55%
Min EPS beat(2)-229.01%
Max EPS beat(2)-124.09%
EPS beat(4)0
Avg EPS beat(4)-127.42%
Min EPS beat(4)-229.01%
Max EPS beat(4)-34.8%
EPS beat(8)2
Avg EPS beat(8)-77.04%
EPS beat(12)6
Avg EPS beat(12)-26.42%
EPS beat(16)9
Avg EPS beat(16)-20.44%
Revenue beat(2)0
Avg Revenue beat(2)-31.63%
Min Revenue beat(2)-43.09%
Max Revenue beat(2)-20.18%
Revenue beat(4)0
Avg Revenue beat(4)-23.68%
Min Revenue beat(4)-43.09%
Max Revenue beat(4)-15.48%
Revenue beat(8)0
Avg Revenue beat(8)-15.48%
Revenue beat(12)1
Avg Revenue beat(12)-10.53%
Revenue beat(16)1
Avg Revenue beat(16)-8.43%
PT rev (1m)0%
PT rev (3m)-37.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS3.56
BVpS-1.36
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -163.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.9%
FCFM N/A
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.93%
ROCE(5y)15.14%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
F-Score4
Asset Turnover2.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.44%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.32
Altman-Z -2.75
F-Score4
WACC4.78%
ROIC/WACCN/A
Cap/Depr(3y)18.03%
Cap/Depr(5y)28.76%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.58%
Profit Quality(3y)218.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-540.63%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-671.43%
EPS Next Y-1584.67%
EPS Next 2Y-154.49%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue 1Y (TTM)-44.13%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-73.26%
Revenue Next Year-52.33%
Revenue Next 2Y-27.82%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%
EBIT growth 1Y-519.9%
EBIT growth 3Y-35.57%
EBIT growth 5Y-11.61%
EBIT Next Year-252.95%
EBIT Next 3Y-38.41%
EBIT Next 5Y-9.53%
FCF growth 1Y-234.51%
FCF growth 3Y24.19%
FCF growth 5Y14.61%
OCF growth 1Y-225.94%
OCF growth 3Y22.32%
OCF growth 5Y15.09%

ZYNEX INC / ZYXI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZYNEX INC (ZYXI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ZYXI.


What is the valuation status for ZYXI stock?

ChartMill assigns a valuation rating of 0 / 10 to ZYNEX INC (ZYXI). This can be considered as Overvalued.


How profitable is ZYNEX INC (ZYXI) stock?

ZYNEX INC (ZYXI) has a profitability rating of 3 / 10.


Can you provide the financial health for ZYXI stock?

The financial health rating of ZYNEX INC (ZYXI) is 1 / 10.